SU 5616

CAS No. 186611-58-5

SU 5616( —— )

Catalog No. M36392 CAS No. 186611-58-5

SU 5616 (WAY-608241) regulates abnormal cell proliferation and modulates tyrosine kinase signaling.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 73 Get Quote
5MG 107 Get Quote
10MG 169 Get Quote
25MG 273 Get Quote
50MG 417 Get Quote
100MG 590 Get Quote
500MG 1224 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SU 5616
  • Note
    Research use only, not for human use.
  • Brief Description
    SU 5616 (WAY-608241) regulates abnormal cell proliferation and modulates tyrosine kinase signaling.
  • Description
    SU 5616 is an organic compound. SU 5616 potentially modulates tyrosine kinase signal transduction, and regulates abnormal cell proliferation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Tyrosinase
  • Recptor
    Tyrosine Kinases
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    186611-58-5
  • Formula Weight
    261.73
  • Molecular Formula
    C13H8ClNOS
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 15.62 mg/mL (59.68 mM; Ultrasonic (<60°C)
  • SMILES
    C(=C1C=2C(NC1=O)=CC=C(Cl)C2)C3=CC=CS3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Tang Peng Cho, et al. Indolinone compounds capable of modulating tyrosine kinase signal transduction: World Intellectual Property Organization, WO9640116 A1. 1996-12-19.
molnova catalog
related products
  • Hexylresorcinol

    Hexylresorcinol is an organic compound with local anaesthetic, antiseptic and anthelmintic properties, is a potent inhibitor of mushroom tyrosinase.

  • EGFR-IN-87

    EGFR-IN-87 is a potent EGFR tyrosine kinase inhibitor with anticancer activity that inhibits EGFR_d746-750, EGFR_L858R/T790M, and EGFR_WT in A431 cells, and can be used for cancer research.

  • Tyrosinase-IN-12

    Tyrosinase-IN-12(Non-competitive tyrosinase inhibitor) is a potent non-competitive tyrosinase inhibitor with an IC50 of 49.33 ± 2.64 μM and a Ki of 31.25 ± 0.25 μM.